168 filings
Page 3 of 9
8-K
gsywap3s
2 Apr 21
Other Events
5:00pm
8-K
1ls0b7x
29 Mar 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:01pm
8-K
6ng415v4u
29 Mar 21
Regulation FD Disclosure
9:18am
8-K
jge496 5w6s
5 Feb 21
Departure of Directors or Certain Officers
4:24pm
8-K
mnfv6n0k 3y
29 Jan 21
Humanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19
7:30am
8-K
le7knvg8o mwk
22 Jan 21
Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19
10:41am
8-K
n86 hmrnik
19 Jan 21
Other Events
5:24pm
8-K
7h5odp6resm
14 Jan 21
Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19
4:30pm
8-K
3emlcmdbios7
11 Jan 21
Regulation FD Disclosure
6:07am
8-K
hoc07
7 Jan 21
Departure of Directors or Certain Officers
4:30pm
8-K
m1gkl
31 Dec 20
Other Events
4:37pm
8-K
3vs69q9dkmtxsrqf
12 Nov 20
Results of Operations and Financial Condition
6:06am
8-K
ufzv4e f5
6 Nov 20
Humanigen Announces Cooperative Research and Development Agreement with the Department of Defense to Develop Lenzilumab for COVID-19
9:05am
8-K
xao 40uy3yol9
4 Nov 20
Humanigen Executes Licensing Agreement for Lenzilumabâ„¢ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea and the Philippines
4:45pm
8-K
f28n63armeflq8 cn4w2
7 Oct 20
Departure of Directors or Certain Officers
4:15pm
8-K
ko12ld
21 Sep 20
Other Events
8:26am
8-K
fbyvl1lfv
11 Sep 20
Departure of Directors or Certain Officers
4:43pm
8-K
iadc26re1d9pxz3545
4 Sep 20
Other Events
4:36pm
8-K
962jfs est
10 Aug 20
Regulation FD Disclosure
9:08am
8-K
gpfss1mgb6dgz
3 Aug 20
Departure of Directors or Certain Officers
8:30am